Results 121 to 130 of about 31,798 (219)

INHIBITORII POMPEI DE PROTONI ȘI RISCUL INFECȚIEI CU CLOSTRIDIOIDES DIFFICILE

open access: yesBuletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale
Infecția cu Clostridioides difficile a fost evidențiată ca o problemă majoră de sănătate publică, inclusiv ca una din cele mai frecvente infecții asociate asistenței medicale.
Nicolae BACINSCHI   +4 more
doaj   +1 more source

Management of Clostridioides difficile infection: an Italian Delphi consensus [PDF]

open access: yes
Background: Clostridioides difficile infection (CDI), a leading cause of nosocomial deaths, is a microbiota-mediated disease. As such, the use of broader spectrum antibiotics, such as vancomycin and metronidazole, can prime the gastrointestinal tract to ...
Armuzzi, Alessandro   +12 more
core   +2 more sources

Dominance of toxigenic Clostridioides difficile strains and the appearance of the emerging PCR ribotype 955 in hospitals in Silesia, Poland

open access: yesFrontiers in Microbiology
IntroductionToxigenic strains of Clostridioides difficile are the leading cause of healthcare-associated bacterial infections in Poland. In the Silesian Voivodeship, with 4.5 million inhabitants, the incidence of C.
Klaudia Szarek   +13 more
doaj   +1 more source

Curbing inappropriate C. difficile treatment in patients receiving concomitant laxatives

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
In the setting of universal Clostridioides difficile screening, we implemented an alert that triggered when C. difficile treatment was ordered in patients who recently received laxatives. This resulted in C.
Paige Fields   +6 more
doaj   +1 more source

A Review of Therapies for Clostridioides difficile Infection

open access: yesAntibiotics
Clostridioides difficile is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of Clostridioides difficile infection (CDI), it remains a ...
Faiza Morado, Neha Nanda
doaj   +1 more source

\u3ci\u3eClostridioides difficile\u3c/i\u3e Infection Study Models and Prospectives for Probing the Microbe-Host Interface [PDF]

open access: yes
Clostridioides difficile infection (CDI) is an urgent public health threat with a high rate of recurrence and limited treatment options. In vivo models have been indispensable in understanding CDI pathophysiology and establishing treatment protocols and ...
Courson, David S.   +2 more
core   +1 more source

Risk factors for further recurrences of Clostridioides difficile infection at the first and second recurrence: a retrospective cohort

open access: yesBMC Infectious Diseases
Background Recurrent Clostridioides difficile infection is most effectively treated with faecal microbiota transplantation. Swedish and European guidelines suggest faecal microbiota transplantation after a first or second recurrence, respectively.
Måns Stefansson   +5 more
doaj   +1 more source

Clostridioides difficile infection: an update

open access: yesInfezioni in Medicina
Clostridioides difficile (C. difficile) is a Gram-positive, spore-forming anaerobic bacterium emerged as a leading cause of diarrhea globally. CDI's (Clostridioides difficile infection) impact on healthcare systems is concerning due to high treatment cost and increased hospitalisation time.
Federica, Salvati   +4 more
openaire   +2 more sources

Evaluation of cases of Clostridioides difficile detected in a tertiary hospital in western Paraná state, Brazil. [PDF]

open access: yes
Background: Clostridioides difficile is an obligate anaerobic, gram-positive bacillus, with subterminal spores. It is also a producer of enterotoxins. Prolonged use of broad-spectrum antimicrobials in immunocompromised patients is often related to the ...
Ayres Torres Takaes, Rodrigo   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy